Medical Products & Devices – US: Fast-growing cardiac products pump new life into select device companies
23 Jan 2020|Moody's Investors Service
Newer, innovative procedures like TAVR will remain a meaningful portion of overall medical device sales, offsetting pricing pressure in mature categories, like stents.
16 Dec 2019|Moody's Investors Service
The rising cost of healthcare and the growing uninsured population underlie the challenges to affordability and access for households, fueling the high social risks for the healthcare sector
19 Nov 2019|Moody's Investors Service
Robard Williams and Rebecca Karnovitz of the Credit Strategy & Research team discuss proposals that would expand access and affordability of health insurance in the US. The proposals, if enacted, would be positive for household consumption and many consumer-facing sectors but be negative for the healthcare sector and would increase fiscal risks for the US sovereign.
25 Nov 2019|Moody's Investors Service
If legislation to curb surprise medical bills limits out-of-network reimbursement to less than $35,000 per transport, it would be detrimental for Air Methods and Global Medical Response.
Expansion of US public health insurance would be positive for US consumers but create fiscal risks for the sovereign
13 Nov 2019|Moody's Investors Service
Public insurance proposals that Improve affordability and access to care for more households would be positive for US consumption. The fiscal impact on the US sovereign would depend on how these programs are financed and the effectiveness of cost saving measures.
04 Nov 2019|Moody's Investors Service
Nick Samuels and Emily Raimes from the US Public Finance team discuss Puerto Rico’s difficult road to recovery despite its debt restructuring. Challenges include negative demographic and economic trends, a Medicaid funding cliff and uncertainty surrounding the federal oversight board’s proposed reform measures.